PROPANC BIOPHARMA, INC. — Operating Income by Fiscal Year
15 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/bde6eaf3-0fd8-4b5a-8107-54dadf6cd8dd/serie/operating-income
| Fiscal year | Operating Income | Period | Evidence |
|---|---|---|---|
| FY 2025 | $-57.3M | 2024-07-01 – 2025-06-30 | evidence 0001493152-25-016069 |
| FY 2024 | $-1.5M | 2023-07-01 – 2024-06-30 | evidence 0001493152-24-038815 |
| FY 2023 | $-1.8M | 2022-07-01 – 2023-06-30 | evidence 0001493152-23-034632 |
| FY 2022 | $-2.0M | 2021-07-01 – 2022-06-30 | evidence 0001493152-22-027033 |
| FY 2021 | $-1.8M | 2020-07-01 – 2021-06-30 | evidence 0001493152-21-023973 |
| FY 2020 | $-3.5M | 2019-07-01 – 2020-06-30 | evidence 0001493152-20-018726 |
| FY 2019 | $-2.6M | 2018-07-01 – 2019-06-30 | evidence 0001493152-19-015529 |
| FY 2018 | $-4.0M | 2017-07-01 – 2018-06-30 | evidence 0001493152-18-013392 |
| FY 2017 | $-5.7M | 2016-07-01 – 2017-06-30 | evidence 0001493152-17-011027 |
| FY 2016 | $-6.9M | 2015-07-01 – 2016-06-30 | evidence 0001144204-16-125808 |
| FY 2015 | $-1.7M | 2014-07-01 – 2015-06-30 | evidence 0001144204-15-057458 |
| FY 2014 | $-761.2k | 2013-07-01 – 2014-06-30 | evidence 0001144204-14-060984 |
| FY 2013 | $-17.4M | 2007-10-15 – 2014-03-31 | evidence 0001354488-14-002818 |
| FY 2012 | $-16.5M | 2007-10-15 – 2013-03-31 | evidence 0001354488-13-003018 |
| FY 2011 | $-12.8M | 2007-10-15 – 2012-03-31 | evidence 0001354488-12-002768 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).